Frailty as an Immune‐Mediated Condition That Leads to an Increased Risk of Acute Cellular Rejection in Liver Transplant Recipients
Laila Fozouni, Jennifer C. Lai – 30 June 2020
Spotlight on Impactful Research: Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study
Jasleen Singh, Eric R. Kallwitz – 30 June 2020
Spotlight on Impactful Research: Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal Study
Jasleen Singh, Eric R. Kallwitz – 30 June 2020
Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis
Sang Bong Ahn, Elizabeth E. Powell, Anthony Russell, Gunter Hartel, Katharine M. Irvine, Chris Moser, Patricia C. Valery – 30 June 2020 – Although there is evidence that type 2 diabetes mellitus (T2D) impacts adversely on liver‐related mortality, its influence on hospital readmissions and development of complications in patients with cirrhosis, particularly in alcohol‐related cirrhosis (the most common etiological factor among Australian hospital admissions for cirrhosis) has not been well studied.
Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study
Yu Fu, Rui Zhu, Tao Bai, Ping Han, Qin He, Mengjia Jing, Xiaofeng Xiong, Xi Zhao, Runze Quan, Chaoyue Chen, Ying Zhang, Meihui Tao, Jianhua Yi, Dean Tian, Wei Yan – 30 June 2020
Reproductive Health and Nonalcoholic Fatty Liver Disease in Women: Considerations Across the Reproductive Lifespan
Monika Sarkar, Ayako Suzuki – 30 June 2020
Issue Information
30 June 2020
AGA Clinical Practice Update on Interaction Between Oral Direct‐Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
Amit G. Singal, Joseph K. Lim, Fasiha Kanwal – 30 June 2020
Update on Alpha‐1 Antitrypsin Deficiency in Liver Disease
Praveena Narayanan, Pramod K. Mistry – 30 June 2020